2011
DOI: 10.1111/j.1473-2165.2011.00549.x
|View full text |Cite
|
Sign up to set email alerts
|

Phosphatidylcholine/deoxycholate lipolysis and hyaluronic acid augmentation to enhance nonsurgical lower facial contouring using botulinum toxin type A

Abstract: Botulinum toxin type A can produce dramatic improvements in patients with benign masseteric hypertrophy but this method alone is not as effective for patients with a rounded lower face. The paper describes the effective use of selective lower jowl phosphatidylcholine/deoxycholate lipolysis and chin, cheek, and nose augmentation with hyaluronic acid to refine cosmetic lower facial contouring using botulinum toxin type A in a young Asian woman. A series of treatments was administered over 26 months. The patient'… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
8
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 6 publications
0
8
0
Order By: Relevance
“…A PubMed review of the English-language medical literature conducted with the search terms “hyaluronic acid filler,” “botulinum,” “face,” “facial,” “Asia,” “Asian,” “Korea,” “Korean,” “China,” “Chinese,” “Thailand,” “Singapore,” “Indonesia,” “Japan,” and “Philippines” was completed before the meeting. Due to the paucity of prospective, randomized, comparative, controlled studies of botulinum toxin and HA fillers in Asian patients (with only one English-language paper on their combination use in Asians [ 25 ] being found), no formal process of evaluating the published clinical evidence could be conducted. The process used to develop the consensus statements presented here has been described [ 12 ].…”
Section: Methods Of Consensus Developmentmentioning
confidence: 99%
See 1 more Smart Citation
“…A PubMed review of the English-language medical literature conducted with the search terms “hyaluronic acid filler,” “botulinum,” “face,” “facial,” “Asia,” “Asian,” “Korea,” “Korean,” “China,” “Chinese,” “Thailand,” “Singapore,” “Indonesia,” “Japan,” and “Philippines” was completed before the meeting. Due to the paucity of prospective, randomized, comparative, controlled studies of botulinum toxin and HA fillers in Asian patients (with only one English-language paper on their combination use in Asians [ 25 ] being found), no formal process of evaluating the published clinical evidence could be conducted. The process used to develop the consensus statements presented here has been described [ 12 ].…”
Section: Methods Of Consensus Developmentmentioning
confidence: 99%
“…Combined treatment results in synergistic improvement compared to individual use of these agents and is used as “age-prevention” treatment in younger patients [ 20 ]. Although numerous papers describing these techniques in Western populations have been published [ 20 – 24 ], only one English-language paper that describes combination injectable treatment in Asians could be found in PubMed [ 25 ].…”
Section: Introductionmentioning
confidence: 99%
“…Existing published recommendations cannot be applied directly to Asians. Furthermore, relatively few published papers cited in PubMed describe the use of botulinum toxin and HA fillers in Asians, and only one paper describes their combined use in the Asian face [ 16 ]. Unfortunately, data from clinical trials are often not relevant to real-world practice because typically only one standardized treatment intervention is studied in one facial area; however, esthetic treatment is usually multimodal and individualized.…”
Section: Introductionmentioning
confidence: 99%
“…However, retreatment may be needed to maintain the desired aesthetic correction because HA degrades over time. The efficacy and safety of HA have been established for facial aesthetic indications, 1623 but information on nasal treatments is limited; clinical experience 7,912,14,15 and data from 2 small studies 8,13 and 1 retrospective case series 24 have been described. Here, the author presents his clinical experience of nasal treatments with HA during 15 years, with case descriptions to illustrate the use of HA as an alternative or complement to primary and secondary rhinoplasty.…”
mentioning
confidence: 99%